> ## Content Index > Fetch the complete content index at: https://ghost.psymposia.com/llms.txt > Use this file to discover other available public pages before exploring further. # Every Disclosed Conflict of Interest at Psychedelic Science 2023 - URL: https://ghost.psymposia.com/maps-psychedelic-science-2023-conflict-of-interest-disclosure/ - Published: 2023-06-22T00:21:35.000Z - Updated: 2023-06-22T13:59:32.000Z - Description: All the financial conflict disclosures from Psychedelics Science 2023 speakers, in one handy list. - Author: Russell Hausfeld - Tags: Magazine, corporadelic, Culture, Ethics, Psychedelics, Science, #wp, #wp-post, #Import 2026-08-25 22:59 --- *All of the financial conflict disclosures from speakers at Psychedelic Science 2023, in one handy list.* \[*Author’s note: There is nothing inherently wrong with having a conflict of interest (COI), and disclosing COIs is a normal thing to do within a scientific field. Declarations of COIs provide important context to audiences as they evaluate information in light of a speaker’s potential motivations, biases, and goals. Because this information is located on a mobile app that is likely to disappear one day, Psymposia is preserving a copy for public reference on its website.*\] T he Psychedelic Science 2023 conference — taking place in Denver from June 19-23 — is hosting over 300 speakers. These speakers were required to declare financial conflicts of interest (COI) to the Postgraduate Institute for Medicine (PIM), an organization which provides continuing education for healthcare professionals. Originally, speakers were asked to declare COIs in a slide of their presentation. This practice is in line with published recommendations in the Journal of the American Medical Association (JAMA) which state that “simple, standardized, and readable disclosure statements are urgently needed **at the point of influential data presentation**” \[emphasis added\]. However, before the conference began, speakers were informed that the COI slide had been removed from their presentations because PIM had aggregated speaker COIs into a list which would be available to conference attendees. “This means that when you are on stage, you will not have your disclosure slide, and you are not required to make a disclosure statement,” speakers were informed in an email from conference organizers. “If you like, you may make a verbal disclosure on stage, but this is not required.” ![](https://ghost.psymposia.com/content/images/www-psymposia-com/wp-content/uploads/2023/06/speakeremail.jpg) *Message sent to Psychedelic Science 2023 speakers regarding COI disclosures (click for a closer view).* The COI list can be found on the Psychedelic Science 2023 mobile app by locating the “Accreditation” tab on the app’s homepage. Halfway through the Accreditation page is the “Disclosure of Conflicts of Interest” section. “All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. The existence or absence of COI for everyone in a position to control educational content is listed below,” the section begins. “Speakers reported the following relevant financial relationships with ineligible entities related to the educational content of this CE \[continuing education\] activity.” “Ineligible entities” is defined by the Accreditation Council for Continuing Medical Education as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.” # [Join Our Newsletter Independent reporting. Critical analysis. In your inbox. ](http://www.psymposia.com/subscribe?ref=ghost.psymposia.com) # [ ](http://www.psymposia.com/subscribe?ref=ghost.psymposia.com) # [Subscribe →](http://www.psymposia.com/subscribe?ref=ghost.psymposia.com) [Join Our Newsletter](https://www.psymposia.com/subscribe?ref=ghost.psymposia.com) [Independent reporting. Critical Analysis.](https://www.psymposia.com/subscribe?ref=ghost.psymposia.com) [In your inbox.](https://www.psymposia.com/subscribe?ref=ghost.psymposia.com) [ ](https://www.psymposia.com/subscribe?ref=ghost.psymposia.com) [Subscribe →](https://www.psymposia.com/subscribe?ref=ghost.psymposia.com) [ ](https://www.psymposia.com/subscribe?ref=ghost.psymposia.com) This list was created by PIM for Psychedelic Science 2023 and may contain unreported COIs and typos. The list reads as follows: **Speakers with nothing to disclose** Adam Safron Adele Lafrance Alan Davis Alex Sherwood Andrea Gomez Anny Ortiz Anthony Bossis Balazs Szigeti Belinda Eriacho Bessel van der Kolk Brandon Weiss Candace Lewis Cedar Barstow Celeste Alvarez Christopher Timmermann Danielle Herrera Danielle Nova/Negrin David Yaden David Esselman David Mathai Deran Young Devon Christie Diana Quinn Eduardo Schenberg Elias Dawkwar Eline Haijen Eric Vermetten Floris Wolswijk Gene Gunn Gita Vaid Glauber Assis Hannes Kettner Igor Adrian Llano Lourido Imran Khan Isabel Weisser Jae Sevelius Janis Phelps Jenna Traynor Jennifer Danby Jessi Humphreys Joe Tafur Jose Carlos Bouso Joshua Gordon Julia Bornemann Julian Mulligan Kate Godfrey Kwasi Adusei Lisa Summer Lorenzo Pasquini Luis Tofoli Marcela Ot’alora G. Mary Cosimano Matthew Boggott \[sic, presumably “Baggott”\] Natalie Gukasyan Natasha Mason Nathan Sepeda Nicholas Cozzi Pamela Kryskow Paul daley Rachel Yehuda Rafaella Lancelotta \[sic, presumably “Elle Lancelotta”\] Raquel Bennet Rebecca Kronman Reilly Capps Richard Schwartz Richard Zeifman Robin McKenna Sara Reed Shayla Love Stephanie Kilpatrick Stevens Rehen Sunny Strasburg Terence Ching Todd Haspect Victor Cabral Xiaojue **Speakers with disclosures** Akua Prieto Brown Employee: Alchemy Community Therapy Center, Doorway Therapeutics, West Coast Therapy and Wellness, The Permanente Medical Group Albert Garcia- Romeu Grant Research: AGR has received research funding from MicroDoz Therapy Inc., Mydecine Innovations Group Inc., Unlimited Sciences, the Council on Spiritual Practices, the Heffter Research Institute, and NIH Grant Research: AGR has received research funding support through the Johns Hopkins Center for Psychedelic and Consciousness Research provided by Tim Ferriss, Matt Mullenweg, Blake Mycoskie, Craig Nerenberg, and the Steven and Alexandra Cohen Foundation Consultant Advisory Board: AGR is a paid scientific advisor to NeonMind Biosciences and InnerWell Andrew Penn Grant Research Support: Usona Institute (research support) Grant Research Support: Filament (research support) Speakers: Compass Pathways(non-CME speaking) Consultant/Advisory Board: Mindmed (consultant) Consultant/Advisory Board: Tactogen (advisory board) Consultant/Advisory Board: Osmind (advisory board) Consultant/Advisory Board: Alexander Shulgin Research Institute (consultant) Consultant/Advisory Board: HMP/Psych Congress (advisory board) Non-Mutual funds Stock Ownership/Stock options: Osmind (stock options) Non-Mutual funds Stock Ownership/Stock options: Tactogen (stock) Other Financial or Material Support: Board of Psychedelic Medicine and Therapies (SME consultant) Other Financial or Material Support: California Institute of Integral Studies (teaching) Other Financial or Material Support: Berkeley Center for Psychedelics (teaching) Anne Wagner Grant/Research Support: MAPS PBC Consultant/Advisory Board: MAPS PBC Anthony Back Grant/Research Support: Cybin, Inc provided an unrestricted educational grant for training therapists for my clinical trial of psilocybin-assisted therapy for doctors and nurses. The grant ends in June 2023. Anya Ermakova Employee/Owner: Beckley Psytech Grant/Research Support: Travel stipend Consultant/Advisory Board: Beckley Psytech, Chacruna Institute, Cactus Conservation Institute Barbara Rothbaum Employee/Owner: Virtually Better, Inc Grant/Research Support: MAPS Consultant/Advisory Board: Otsuka, Senseye Ben Sessa Employee/Owner: Former co-founder and Head of Psychedelic Medicine at Awakn Life Sciences. (Employment ended on 14th April 2023) Consultant/Advisory Board: Former co-founder and Head of Psychedelic Medicine at Awakn Life Sciences. (Employment ended on 14th April 2023) Non-Mutual funds Stock Ownership/Stock options: Yes, I still own shares / stock at Awakn Life Sciences Benjamin Kelmendi Consultant/Advisory Board: Transcend Therapeutics Berra Yazar-Klosinski Employee/Owner: Employee of Multidisciplinary Association for PsychedelicStudies (MAPS) Aug 2009-Apr 2022 Employee/Owner: Employee of MAPS Public Benefit Corporation Apr 2022-May 2023 Betsy Jenkins Non-Mutual funds Stock Ownership/Stock options: Stock ownership Compass Pathways (400 shares) Boris Heifets Grant/Research Support: NIMH R01 Consultant/Advisory Board: SAB member, Osmind Mental Health Consultant/Advisory Board: SAB member, Journey Clinical Non-Mutual funds Stock Ownership/Stock options: Osmind Mental Health, <1% equity Non-Mutual funds Stock Ownership/Stock options: Journey Clinical, <1% equity Broc Pagni Employee/Owner: New York University Grant/Research Support: Post-doctoral Trainee Program Chandra Khalifian Employee/Owner: California Couples Clinic Grant/Research Support: VA RR&D: RX003490 Consultant/Advisory Board: Persephone Charles Grob Grant/Research Support: Cohen Foundation Grant/Research Support: Sandburg Foundation Grant/Research Support: Gordon Foundation Grant/Research Support: Norris FOundation Grant/Research Support: Anon Foundation Consultant/Advisory Board: Lobe Sciences (scientific advisory panel) Patent Holder/Royalties paid to you: Guilford Press Charles Nichols Employee/Owner: 2A Biosciences- Cofounder, Board Member, equity holder Grant/Research Support: Eleusis Therapeutics Grant/Research Support: 2A Biosciences Consultant/Advisory Board: Palo Santo Charles Raison Consultant/Advisory Board: Usona Institute Consultant/Advisory Board: Novartis Consultant/Advisory Board: Sage/Biogen Chris Stauffer Consultant/Advisory Board: Paid supervisor/educator for MAPS Public Benefit Corporation Other financial or material support: Received psilocybin for clinical trial from Usona and MDMA for clinical trial from MPBC Claudia Cuentas Employee/Owner: lAlma Institute (www.almatraining.org)\~ Instructor for their Psilocybin training program and Cultural Director. Consultant/Advisory Board: SoundMind Institute (consultant and guess lecture) Cody Swift Employee/Owner: Riverpsykhe INC. Employee/Owner: Johns Hopkins University Consultant/Advisory Board: Indigenous Medicine Conservation Fund (board) Consultant/Advisory Board: Indigenous Peyote Conservation Initiative (board seat ended) Consultant/Advisory Board: B.More Heffter Research Institute Cody Wenthur Grant/Research Support: Psilera Inc – Research Contract Speakers Bureau/Honoraria for non-CME: Genomind – Honorarium for Speaking Speakers Bureau/Honoraria for non-CME: Horizons NY – Honorarium for Speaking Consultant/Advisory Board: Psychedelic Pharmacists Association – Unpaid Advisor Consultant/Advisory Board: Intercollegiate Psychedelic Network – Unpaid Advisor Corine de Boer Employee/Owner: Employee MAPS Public Benefit Corporation Employee/Owner: Owner Tulip Medical Consulting LLC Consultant/Advisory Board: Member Advisory Council Not Putting on a Shirt (registered charity) Daniel Gehrlach Employee/Owner: Employee: HMNC Holding GmbH (HMNC Brain Health) Daniel Roberts Employee/Owner: Daniel E. Roberts, MD (private psychiatry practice) Consultant/Advisory Board: HQ Digital- Guest Speaker Other Financial or Material Support: Fluence-training faculty-independent contractor (psychedelic education company) Daniela Burner Employee/Owner: PsychoGenics Grant/Research Support: NIH David Erritzoe Employee/Owner: Imperial College London Grant/Research Support: For the work in focus for this presentation funding comes from SmallPharma Ltd Consultant/Advisory Board: Aya Biosciences Consultant/Advisory Board: Mindstate Lab Consultant/Advisory Board: Clerkenwell Health Non-Mutual funds Stock Ownership/Stock options: Stock options in Field Trip Other financial or material support: Work at Imperial College’s Centre for Psychedelic Research supported by: https://www.imperial.ac.uk/psychedelic-research-centre/funding/our-generous-supporters/ David Nutt Employee/Owner: Awaknlifesciences Grant/Research Support: COMPASSPathways Grant/Research Support: Usona Grant/Research Support: Filament Grant/Research Support: Beckley Psytec Speakers Bureau/Honoraria for non-CME: Takeda Speakers Bureau/Honoraria for non-CME: Otsuka Speakers Bureau/Honoraria for non-CME: Lundbeck Consultant/Advisory Board: Alvarius Consultant/Advisory Board: Neuraltherapeutics Consultant/Advisory Board: Algernon Non-Mutual funds Stock Ownership/Stock options: Psyched Wellness Patent Holder/ Royalties paid to you: Awaknlifesciences Draulio Barros de Araujo Grant/Research Support: Brazilian government Consultant/Advisory Board: Biomind Labs (ended on Dec. 2022) Emmanuelle Schindler Grant/Research Support: Ceruvia Lifesciences Consultant/Advisory Board: PureTech Patent Holder/ Royalties paid to you: Named owner on patent: Psychedelic Treatment for Headache Disorders \[17/168,638 (US); 2021709245 (EP); 3,166,785 (CA); 2022-547896 (JP)\] Erika Dyck Grant/Research Support: Social Sciences and Humanities Research Council of Canada Consultant/Advisory Board: Psychedelic Science Advisory Committee (Queens University, Canada) Consultant/Advisory Board: Chacruna Institute for Psychedelic Plant Medicines (Not-for-Profit, Board Member) Frederick Barrett Grant/Research Support: Steven and Alexandra Cohen Foundation, Grant/Research Support: Wana Brand Foundation, Grant/Research Support: PharmaDrug Inc Speakers Bureau/Honoraria for non-CME: The University of Pennsylvania Speakers Bureau/Honoraria for non-CME: University of California-Davis Speakers Bureau/Honoraria for non-CME: University of Southern California Consultant/Advisory Board: WavePaths, Ltd Consultant/Advisory Board: MindState Design Labs, Inc Consultant/Advisory Board: Gilgamesh Pharmaceuticals, Inc Consultant/Advisory Board: Atai Life Sciences Gabby Agin-Liebes Grant/Research Support: NIH T32DA007233 Patent Holder/Royalties paid to you: I am the inventor on patents filed by NYU for the use of psilocybin to treat existential distress associated with cancer and suicidality, but I have waived rights to this intellectual property and have no prospect of financial benefit. I am not currently employed by NYU. Gul Dolen Consultant/Advisory Board: MIND Institute Consultant/Advisory Board: Compass Pathways Consultant/Advisory Board: Pangea Biosciences Patent Holder/Royalties paid to you: U.S. Patent Application No.: 63/120,657/ Eleusis LLC (license holder) Haley Maria Dourron Grant/Research Support: Source Research Foundation Other financial or material support: University of Alabama at Birmingham Harriet de Wit Grant/Research Support: NIH Research Grant Consultant/Advisory Board: Gilgamesh Pharmaceuticals Consultant/Advisory Board: Awakn life Sciences Consultant/Advisory Board: MIND Foundation Non-Mutual funds Stock Ownership/Stock options: PharmAla Biotech Other financial or material support: Editorial duties for scientific journal Springer-Nature Heidi Allen Grant/Research Support: Steven & Alexandra Cohen Foundation Grant/Research Support: Joe & Sandy Samberg Foundation Consultant/Advisory Board: Usona Institute (upaid) Consultant/Advisory Board: RWJF Policies for Action National Advisory Committee (unpaid) Consultant/Advisory Board: Medicaid and CHIP Payment and Access Commission Ingmar Gorman Consultant/Advisory Board: Journey Clinical Non-Mutual funds Stock Ownership/Stock options: Journey Clinical Non-Mutual funds Stock Ownership/Stock options: Beckley Psytech James Close Employee/Owner: Imperial College London Employee/Owner: Centre for Psychedelic Research Grant/Research Support: Imperial College London Grant/Research Support: Centre for Psychedelic Research James Keim Employee/Owner: Both & Discovery, a Public Benefit Corporation Employee/Owner: BluSpectrum Employee/Owner: Mimosa Therapeutics, a Public Benefit Corporation Consultant/Advisory Board: Advisor to the Alexander Shulgin Research Institute Consultant/Advisory Board: Advisor to Mindlumen Jason Wallach Employee/Owner: Saint Joseph’s University (Employer) Grant/Research Support: Compass Pathways (Contract) Grant/Research Support: Bexson Biomedical (Contract) Grant/Research Support: PA Department of Health (Grant) Consultant/Advisory Board: Pangea (Consultant) Consultant/Advisory Board: Compass Pathways (Consultant) Consultant/Advisory Board: Bexson Biomedical (Consultant) Consultant/Advisory Board: Progressive Therapeutics (Consultant) Non-Mutual funds Stock Ownership/Stock options: Bexson Biomedical (Shares and options) Non-Mutual funds Stock Ownership/Stock options: Compass Pathways (Options) Patent Holder/ Royalties paid to you: I am an inventor on several patents and pending patent applications. Jay Nair Employee/Owner: MAPS PBC Employee Jennifer Jones Consultant/Advisory Board: MAPS PBC Consultant/Advisory Board: JEDI Consultant Other Financial or Material Support: Philadelphia FIGHT Other Financial or Material Support: Columbia University Other Financial or Material Support: CIIS Other Financial or Material Support: MAPS PBC Trainer Jennifer Mitchell Grant/Research Support: MAPS/MAPSPBC Jessica Nielson Grant/Research Support: National Institutes of Health (R01 MH116156; UL1 TR002494/TR/NCATS) Grant/Research Support: Heffter Research Institute Grant/Research Support: Young Investigator Program Grant/Research Support: University of Minnesota Foundation Other financial or material support: Sub-investigator on COMPASS Pathways phase III clinical trial for treatment resistant depression (NCT05624268). Joel Castellanos Grant/Research Support: Cohen Foundation Consultant/Advisory Board: Tryp Therapeutics Patent Holder/ Royalties paid to you: Springer Publishing Jordan Sloshower Consultant/Advisory Board: Usona Institute Consultant/Advisory Board: Cybin Katrin Preller Employee: Boehringer Ingelheim GmbH & Co KG Fa Hoffmann – La Roche Kelley O’Donnell Grant/Research Support: Usona Institute Grant/Research Support: B.More Grant/Research Support: MAPS-Public Benefit Corporation (MPBC) Grant/Research Support: MindMed Other financial or material support: MPBC Keren Tzarfaty Employee/Owner: MAPS Israel CEO Other financial or material support: MAPS – Contractor (adcovacy work in Israel) Other financial or material support: MPBC – Contractor: senior trainer, supervisor and therapist Kevin Franciotti Employee/Owner: Ballen Medical & Wellness: W-2 Full-time employee Employee/Owner: Behavioral Health Group: W-2 Full-time employee Speakers Bureau/Honoraria for non-CME: Peaks Recovery: received speaker honoraria for panel during The Advanced International Winter Symposium on Addictive Disorders, Behavioral Health, and Mental Health Non-Mutual funds Stock Ownership/Stock options: Compass Pathways (2 shares) Non-Mutual funds Stock Ownership/Stock options: ATAI Life Sciences (10 shares) Non-Mutual funds Stock Ownership/Stock options: MindMed (1.46 shares) Kurt Rasmussen Employee/Owner: Deluxe Therapeutics Consultant/Advisory Board: Curie Bio Consultant/Advisory Board:Freedom Biosciences Lynnette Averill Employee/Owner: NPSYT Employee/Owner: PLLC Consultant/Advisory Board: Transcend Therapeutics Consultant/Advisory Board: Boend Consultant/Advisory Board: Reason for Hope Other financial or material support: Zed3 Manish Agrawal Employee/Owner: Sunshine Therapies Manoj Doss Consultant/Advisory Board: VCENNA, Inc. – Scientific consultant Consultant/Advisory Board: Ocean Bio Ltd. – Scientific consultant Maria Balaet Grant/Research Support: Medical Research Council Doctoral Training Programme at Imperial College London Matthew Johnson Grant/Research Support: Mydedine Innovations group Consultant/Advisory Board: AJNA Labs LLC Consultant/Advisory Board: AWAKN Life Sciences Inc. Consultant/Advisory Board: Beckley Psychedelic Ltd. Consultant/Advisory Board: Reunion Neurosciences Consultant/Advisory Board: Mind Medicine Inc. Consultant/Advisory Board: Negev Capital Consultant/Advisory Board: Otsuka Pharmaceutical Development & Commercialization Inc. Consultant/Advisory Board: Silo Pharma Consultant/Advisory Board: Entheon Inc. Non-Mutual funds Stock Ownership/Stock options: AJNA Labs LLC Non-Mutual funds Stock Ownership/Stock options: AWAKN Life Sciences Inc. Non-Mutual funds Stock Ownership/Stock options: Beckley Psychedelic Ltd. Non-Mutual funds Stock Ownership/Stock options: Reunion Neurosciences Non-Mutual funds Stock Ownership/Stock options: Mind Medicine Inc. Michael Bogenschutz Grant/Research Support: Mind Medicine, Inc. Grant/Research Support: Tilray Canada Grant/Research Support: The Multidisciplinary Association for Psychedelic Studies (MAPS) PBC Grant/Research Support: B.More, Inc. Consultant/Advisory Board: Ajna Labs LLC Consultant/Advisory Board: Journey Colab Consultant/Advisory Board: Bright Minds Biosciences, Inc. Michael Mithoefer Consultant/Advisory Board: MAPS Public Benefit Corporation Consultant/Advisory Board: Senior Medical Director (Contractor) Awakn Scicnes Consultant/Advisory Board: Scientific Advisory Board NiCole Buchanan Employee/Owner: Michigan State University (I am employed by the university, but I am not associated with their work related to patients) Employee/Owner: Board of Psychedelic Medicine and Therapies (Interim CEO, creating credentialing standards for practitioners) Grant/Research Support: National Science Foundation (I receive grant support for unrelated research, not healthcare related research) Nicole Galvao Coelho Employee/Owner: Permanent employee, Associate Professor, Universidade Federal do Rio Grande do Norte, Brazil. Other financial or material support: Researcher fellowship; CAPES Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brazil Nolan Williams Grant/Research Support: NIMH, Grant/Research Support: One Mind, Grant/Research Support: FFOR Grant/Research Support: Welcome Leap Consultant/Advisory Board: Magnus Medical, Consultant/Advisory Board: Sooma, Consultant/Advisory Board: Neurawell Non-Mutual funds Stock Ownership/Stock options: Magnus Medical Pamela Kryskow Consultant/Advisory Board: Unpaid consultant for – Nectara Wellness, Synaptic Care Consultant/Advisory Board: Scientific Advisor – Mycomedica Life Sciences PBC Consultant/Advisory Board: Clinical Advisor – Numinus Non-Mutual funds Stock Ownership/Stock options: Mycomedica Life Sciences PBC Paul Liknaitzky Grant/Research Support: Incannex Healthcare Ltd Consultant/Advisory Board: Incannex Healthcare Ltd Paul Summergrad Consultant/Advisory Board: Compass Pathways Consultant/Advisory Board: Pear Therapeutics Consultant/Advisory Board: Owl Inc Non-Mutual funds Stock Ownership/Stock options: Karuna Non-Mutual funds Stock Ownership/Stock options: Eli Lilly Non-Mutual funds Stock Ownership/Stock options: Owl Inc Non-Mutual funds Stock Ownership/Stock options: Sensorium Non-Mutual funds Stock Ownership/Stock options: Health and Productivity Sciences, Inc Peter Hendricks Consultant/Advisory Board: Bright Minds Biosciences Ltd., Consultant/Advisory Board: Eleusis Benefit Corporation, Consultant/Advisory Board: Journey Colab Corporation, Consultant/Advisory Board: Reset Pharmaceuticals Inc., Consultant/Advisory Board: Silo Pharma. Other financial or material support: Research funding from the NIH. Other financial or material support: Research funding from the Heffter Research Institute Rakesh Jain Grant/Research Support: AbbVie (Allergan) Grant/Research Support: Lilly Grant/Research Support: Lundbeck Grant/Research Support: Otsuka Grant/Research Support: Pfizer Grant/Research Support: Shire Grant/Research Support: Takeda Speakers Bureau/Honoraria for non-CME: AbbVie (Allergan) Speakers Bureau/Honoraria for non-CME: Alkermes Speakers Bureau/Honoraria for non-CME: Axsome Speakers Bureau/Honoraria for non-CME: Corium Speakers Bureau/Honoraria for non-CME: Eisai Speakers Bureau/Honoraria for non-CME: Indivior Speakers Bureau/Honoraria for non-CME: Intra-Cellular Therapies Speakers Bureau/Honoraria for non-CME: Ironshore Pharmaceuticals Speakers Bureau/Honoraria for non-CME: Janssen Speakers Bureau/Honoraria for non-CME: Lilly Speakers Bureau/Honoraria for non-CME: Lundbeck Speakers Bureau/Honoraria for non-CME: Merck Speakers Bureau/Honoraria for non-CME: Neos Therapeutics Speakers Bureau/Honoraria for non-CME: Neurocrine Speakers Bureau/Honoraria for non-CME: Otsuka Speakers Bureau/Honoraria for non-CME: Pamlab Speakers Bureau/Honoraria for non-CME: Pfizer Speakers Bureau/Honoraria for non-CME: Shire Speakers Bureau/Honoraria for non-CME: Sunovion Speakers Bureau/Honoraria for non-CME: Takeda Speakers Bureau/Honoraria for non-CME: Teva Speakers Bureau/Honoraria for non-CME: Tris Pharmaceuticals Consultant/Advisory Board: AbbVie (Allergan) Consultant/Advisory Board: Acadia Consultant/Advisory Board: Adamas Consultant/Advisory Board: Alfasigma Consultant/Advisory Board: Axsome Consultant/Advisory Board: Biogen Consultant/Advisory Board: Boehringer Ingelheim Consultant/Advisory Board: Corium Consultant/Advisory Board: Cingulate Therapeutics Consultant/Advisory Board: Eisai Consultant/Advisory Board: Evidera Consultant/Advisory Board: Impel Consultant/Advisory Board: Janssen Consultant/Advisory Board: Lilly Consultant/Advisory Board: Lundbeck Consultant/Advisory Board: Merck Consultant/Advisory Board: Neos Therapeutics Consultant/Advisory Board: Neurocrine Biosciences Consultant/Advisory Board: Osmotica Consultant/Advisory Board: Otsuka Consultant/Advisory Board: Pamlab Consultant/Advisory Board: Pfizer Consultant/Advisory Board: Sage Therapeutics Consultant/Advisory Board: Shire Consultant/Advisory Board: Sunovion Consultant/Advisory Board: Supernus Consultant/Advisory Board: Takeda Consultant/Advisory Board: Teva Consultant/Advisory Board: Transcend Therapeutics Consultant/Advisory Board: Usona Rebecca Kronman Employee/Owner: Journey Clinical Consultant/Advisory Board: Journey Clinical Robin Carhart-Harris Consultant/Advisory Board: TRYP therapeutics Consultant/Advisory Board: Usona Institute Consultant/Advisory Board: Journey Collab’ Consultant/Advisory Board: Osmind Consultant/Advisory Board: Maya Health Consultant/Advisory Board: Beckley Psytech Consultant/Advisory Board: Anuma Consultant/Advisory Board: MindState Consultant/Advisory Board: Entheos Labs Roland Griffiths Grant/Research Support: Usona Research Institute – Site PI on multisite psilocybin depression trial Consultant/Advisory Board: Heffter Research Institute – Member of Board of Directors Roxanne Sholevar Consultant/Advisory Board: Compass Pathways Sandeep Nayak Grant/Research Support: The Center for Psychedelic and Consciousness Research is funded by philanthropic support from the Steven and Alexandra Cohen Foundation, as well as Tim Ferriss, Matt Mullenweg, Blake Mycoskie, and Craig Nerenberg Speakers Bureau/Honoraria for non-CME: Ross Center — honorarium for CME event Sarah Abedi Employee/Owner: Pacific Neuroscience Institute Employee/Owner: West LA VA Medical Center Grant/Research Support: MAPS Grant/Research Support: Evolve Grant/Research Support: Usona Grant/Research Support: MindMed Consultant/Advisory Board: TREAT California Initiative Saundra Jain Speakers Bureau/Honoraria for non-CME: Lilly Speakers Bureau/Honoraria for non-CME: Otsuka Consultant/Advisory Board: Lilly Consultant/Advisory Board: Otsuka Consultant/Advisory Board: Pamlab Consultant/Advisory Board: Sunovion Sidarta Ribeiro Employee/Owner: Federal University of Rio Grande do Norte (UFRN) Employee/Owner: Fundação Oswaldo Cruz (FIOCRUZ) Grant/Research Support: Bial Foundation Grant/Research Support: Boehringer-Ingelheim International GmbH Consultant/Advisory Board: Chacruna Institute Non-Mutual funds Stock Ownership/Stock options: Psychomeasure Non-Mutual funds Stock Ownership/Stock options: Piauhy Stacy Fisher Grant/Research Support: NCI 1R01CA268521-01A (MPI Ross/Fischer) “Psilocybin therapy for Advanced Cancer-related Psychiatric Distress” (7/22 – 6/27) Stephen Ross Grant/Research Support: Usona Institute Grant/Research Support: Reset Pharmaceuticals Grant/Research Support: Multidisciplinary Association of Psychedelic Studies (MAPS) Grant/Research Support: Mind Medicine Patent Holder/Royalties paid to you: Dr Ross is listed as a co-inventor in two patent applications (N420838US and N419987US) related to the use of psilocybin to treat psychiatric and existential distress in cancer, filed by New York University Grossman School of Medicine and licensed by Reset Pharmaceuticals. Dr Ross has waived all rights and has no prospect of financial gain in relation to these patent applications. Tehseen Noorani Consultant/Advisory Board: Tactogen PBC (part-time scholar-in-residence) Timothy Brewerton Employee/Owner: Timothy D. Brewerton, MD, LLC (owner) Employee/Owner: Monte Nido & Affiliates (Director of Clinical Outcomes & Research) Employee/Owner: Sylvia The Wood Nymph, LLC (founder, owner,executive producer) Grant/Research Support: Monte Nido & Affiliates Speakers Bureau/Honoraria for non-CME: Psychopharmacology Institute Speakers Bureau/Honoraria for non-CME: Psychiatry Redefined Consultant/Advisory Board: Multidisciplinary Association for Psychedelic Studies (MAPS) Consultant/Advisory Board: Eating Recovery Center & Pathlight Programs Consultant/Advisory Board: Sun Cloud Health Consultant/Advisory Board: Resiliency Technologies, Inc. Consultant/Advisory Board: RiverMend Health Patent Holder/Royalties paid to you: Springer Publishing (royalties) Patent Holder/Royalties paid to you: Taylor and Francis (royalties) Tom Insel Employee/Owner: NeuraWell Therapeutics Employee/Owner: Humanest Care Employee/Owner: Valera Health Employee/Owner: Vanna Health Speakers Bureau/Honoraria for non-CME: Penguin Random House Speakers Bureau Consultant/Advisory Board: Alto Neuroscience Consultant/Advisory Board: Compass Pathways Consultant/Advisory Board: NeuraWell Therapeutics Consultant/Advisory Board: Valera Health Non-Mutual funds Stock Ownership/Stock options: Alto Neuroscience Non-Mutual funds Stock Ownership/Stock options: Compass Pathways Non-Mutual funds Stock Ownership/Stock options: Humanest Care Non-Mutual funds Stock Ownership/Stock options: Karuna Therapeutics Non-Mutual funds Stock Ownership/Stock options: Mindstrong Health Non-Mutual funds Stock Ownership/Stock options: NeuraWell Therapeutics Non-Mutual funds Stock Ownership/Stock options: Owl Insight Non-Mutual funds Stock Ownership/Stock options: Valera Health Non-Mutual funds Stock Ownership/Stock options: Vanna Health Tommaso Barba Consultant/Advisory Board: Beautiful Space Wellness Willie Siu Non-Mutual funds Stock Ownership/Stock options: Bexson Biomedical Non-Mutual funds Stock Ownership/Stock options: People Science Yarelix Estrada Grant/Research Support: CDC OD2A for research Consultant/Advisory Board: Board of Directors for the Tennessee Recovery Alliance Consultant/Advisory Board: Board of Directors for the Source Research Foundation Consultant/Advisory Board: Advisory Board of Psymposia Consultant/Advisory Board: Advisory Board of Cardea Yvan Beaussant Grant/Research Support: Research grant received from Sunstone Therapies Grant/Research Support: Research grant received from Cy Biopharma **Hey! Before you go…** Psymposia is a 501(c)(3) non-profit media organization that offers critical perspectives on drugs, politics, and culture. We strive to ask challenging questions, and we’re committed to independent reporting, critical analysis, and holding those who wield power accountable. Our perspectives are informed by critical analysis of the systemic crises of capitalism that have directly contributed to the unmitigated growth of addiction, depression, suicide, and the unraveling of our social relations. The same economic elite and powerful corporate interests who have profited from causing these problems are now proposing “solutions”—solutions which both line their pockets and mask the necessity of structural change. In order for us to keep unpacking these issues and informing our audience, we need your continuing support. **You can sustain Psymposia by becoming a supporter for as little as $2 a month.** [Become a supporter on Patreon today](http://www.patreon.com/psymposia?ref=ghost.psymposia.com) ➤